231 related articles for article (PubMed ID: 18684831)
1. Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity.
Stewart-Maynard KM; Cruceanu M; Wang F; Vo MN; Gorelick RJ; Williams MC; Rouzina I; Musier-Forsyth K
J Virol; 2008 Oct; 82(20):10129-42. PubMed ID: 18684831
[TBL] [Abstract][Full Text] [Related]
2. Aromatic residue mutations reveal direct correlation between HIV-1 nucleocapsid protein's nucleic acid chaperone activity and retroviral replication.
Wu H; Mitra M; McCauley MJ; Thomas JA; Rouzina I; Musier-Forsyth K; Williams MC; Gorelick RJ
Virus Res; 2013 Feb; 171(2):263-77. PubMed ID: 22814429
[TBL] [Abstract][Full Text] [Related]
3. C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.
Qualley DF; Stewart-Maynard KM; Wang F; Mitra M; Gorelick RJ; Rouzina I; Williams MC; Musier-Forsyth K
J Biol Chem; 2010 Jan; 285(1):295-307. PubMed ID: 19887455
[TBL] [Abstract][Full Text] [Related]
4. Single aromatic residue location alters nucleic acid binding and chaperone function of FIV nucleocapsid protein.
Wu H; Wang W; Naiyer N; Fichtenbaum E; Qualley DF; McCauley MJ; Gorelick RJ; Rouzina I; Musier-Forsyth K; Williams MC
Virus Res; 2014 Nov; 193():39-51. PubMed ID: 24915282
[TBL] [Abstract][Full Text] [Related]
5. Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.
Wu T; Gorelick RJ; Levin JG
Virus Res; 2014 Nov; 193():52-64. PubMed ID: 24954787
[TBL] [Abstract][Full Text] [Related]
6. Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.
Mirambeau G; Lyonnais S; Gorelick RJ
RNA Biol; 2010; 7(6):724-34. PubMed ID: 21045549
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.
Post K; Olson ED; Naufer MN; Gorelick RJ; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
Retrovirology; 2016 Dec; 13(1):89. PubMed ID: 28034301
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: implications for genomic RNA packaging.
Sun M; Grigsby IF; Gorelick RJ; Mansky LM; Musier-Forsyth K
J Virol; 2014 Jan; 88(2):1271-80. PubMed ID: 24227839
[TBL] [Abstract][Full Text] [Related]
9. Targeted binding of nucleocapsid protein transforms the folding landscape of HIV-1 TAR RNA.
McCauley MJ; Rouzina I; Manthei KA; Gorelick RJ; Musier-Forsyth K; Williams MC
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13555-60. PubMed ID: 26483503
[TBL] [Abstract][Full Text] [Related]
10. Single-molecule stretching studies of RNA chaperones.
Wu H; Rouzina I; Williams MC
RNA Biol; 2010; 7(6):712-23. PubMed ID: 21045548
[TBL] [Abstract][Full Text] [Related]
11. Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications.
Wu T; Datta SA; Mitra M; Gorelick RJ; Rein A; Levin JG
Virology; 2010 Sep; 405(2):556-67. PubMed ID: 20655566
[TBL] [Abstract][Full Text] [Related]
12. RNA Structural Requirements for Nucleocapsid Protein-Mediated Extended Dimer Formation.
Chaminade F; Darlix JL; Fossé P
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337013
[TBL] [Abstract][Full Text] [Related]
13. Structure/function mapping of amino acids in the N-terminal zinc finger of the human immunodeficiency virus type 1 nucleocapsid protein: residues responsible for nucleic acid helix destabilizing activity.
Narayanan N; Gorelick RJ; DeStefano JJ
Biochemistry; 2006 Oct; 45(41):12617-28. PubMed ID: 17029416
[TBL] [Abstract][Full Text] [Related]
14. A guanosine-centric mechanism for RNA chaperone function.
Grohman JK; Gorelick RJ; Lickwar CR; Lieb JD; Bower BD; Znosko BM; Weeks KM
Science; 2013 Apr; 340(6129):190-5. PubMed ID: 23470731
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger function of HIV-1 nucleocapsid protein is required for removal of 5'-terminal genomic RNA fragments: a paradigm for RNA removal reactions in HIV-1 reverse transcription.
Hergott CB; Mitra M; Guo J; Wu T; Miller JT; Iwatani Y; Gorelick RJ; Levin JG
Virus Res; 2013 Feb; 171(2):346-55. PubMed ID: 23149014
[TBL] [Abstract][Full Text] [Related]
16. Single DNA molecule stretching measures the activity of chemicals that target the HIV-1 nucleocapsid protein.
Cruceanu M; Stephen AG; Beuning PJ; Gorelick RJ; Fisher RJ; Williams MC
Anal Biochem; 2006 Nov; 358(2):159-70. PubMed ID: 17034752
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic nucleic acid dynamics modulates HIV-1 nucleocapsid protein binding to its targets.
Bazzi A; Zargarian L; Chaminade F; De Rocquigny H; René B; Mély Y; Fossé P; Mauffret O
PLoS One; 2012; 7(6):e38905. PubMed ID: 22745685
[TBL] [Abstract][Full Text] [Related]
18. The nucleic acid chaperone activity of the HIV-1 Gag polyprotein is boosted by its cellular partner RPL7: a kinetic study.
Karnib H; Nadeem MF; Humbert N; Sharma KK; Grytsyk N; Tisné C; Boutant E; Lequeu T; Réal E; Boudier C; de Rocquigny H; Mély Y
Nucleic Acids Res; 2020 Sep; 48(16):9218-9234. PubMed ID: 32797159
[TBL] [Abstract][Full Text] [Related]
19. Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.
Garg D; Torbett BE
Virus Res; 2014 Nov; 193():135-43. PubMed ID: 25026536
[TBL] [Abstract][Full Text] [Related]
20. Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid protein.
McGrath CF; Buckman JS; Gagliardi TD; Bosche WJ; Coren LV; Gorelick RJ
J Virol; 2003 Aug; 77(15):8524-31. PubMed ID: 12857921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
